Friday, May 17, 2024
HomePharma

Pharma

Pharma

EuBiologics: Phase III Clinical Trial IND Approval of EuCorVac-19, COVID-19 Vaccine Candidate, in South Korea

Life Sciences Times - 0
Pharma

UroGen Announces Start of Pivotal Single-Arm Phase 3 Trial for UGN-102, an Investigational Non-Surgical Treatment for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Life Sciences Times - 0
Pharma

NorthSea Therapeutics Initiates Phase 1 Trial of SEFA-6179, Targeting the Orphan Indication Intestinal Failure-Associated Liver Disease

Life Sciences Times - 0
Pharma

n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines for Patients with Nano-rare Diseases

Life Sciences Times - 0
Pharma

Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY™

Life Sciences Times - 0
Pharma

Aldeyra Therapeutics Announces Publication of Phase 2 Clinical Trial of Reproxalap in Allergen Chamber Model

Life Sciences Times - 0
Pharma

Merz Aesthetics Launches Radiesse® (+) as First and Only Aesthetic Injectable to Improve Moderate to Severe Loss of Jawline Contour

Life Sciences Times - 0
Pharma

Model N Announces New SaaS Solution for Pharmaceutical and Biotech Companies to Address State Price Transparency Mandates

Life Sciences Times - 0
Pharma

FDA Approves Prophylactic Treatment with VONVENDI®

Life Sciences Times - 0
Pharma

U.S. FDA Approves New Label Update for CAR T-Cell Therapy Yescarta® Showing Prophylactic Steriod Use Improves Management of Cytokine Release Syndrome

Life Sciences Times - 0
Pharma

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies

Life Sciences Times - 0
Pharma

ReForm Biologics Changes Name to Comera Life Sciences

Life Sciences Times - 0
1...262728...56Page 27 of 56

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv